CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 0.9410
-0.0090 (-0.95%)
Mar 26, 2026, 3:22 PM GMT
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 10.8 million as of March 26, 2026. Its market cap has decreased by -63.81% in one year.
Market Cap
10.80M
Enterprise Value
9.19M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.94
Market Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 10.80M, a decrease of -47.00%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 10.80M | -13.64% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.19B |
| GSK plc | 82.14B |
| Haleon | 32.31B |
| Smith & Nephew | 10.28B |
| Cizzle Biotechnology Holdings | 11.10M |
| Genflow Biosciences | 9.91M |
| Renalytix | 9.61M |
| Oxford BioDynamics | 9.01M |